Pharmacotherapy of respiratory muscles.
This article assesses the role of pharmacotherapy in the management of respiratory muscle dysfunction. It focuses on two classes of drugs, the methylxanthines and the sympathomimetic agents. A prospective section focuses also on the particularities of the diaphragm among the skeletal striated muscles. In addition, a new approach to respiratory pharmacotherapy, which may be beneficial in patients with respiratory muscle dysfunction, is suggested.
Aubier
M
M
Clinique Pneumologique, Hôpital Beaujon, Clichy, France.
D000818:Animals; D002110:Caffeine / Q000494:pharmacology*; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects*; D012131:Respiratory Insufficiency / Q000188:drug therapy; D012132:Respiratory Muscles / Q000187:drug effects* / Q000502:physiology; D013268:Stimulation, Chemical; D013566:Sympathomimetics / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology*
D013566:Sympathomimetics; D002110:Caffeine; D013806:Theophylline